ADC Therapeutics | 10-Q: Q3 2024 Earnings Report
ADC Therapeutics | 8-K: ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update
ADC Therapeutics | 10-Q: Q2 2024 Earnings Report
ADC Therapeutics | 8-K: ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
ADC Therapeutics | 10-Q: Q1 2024 Earnings Report
ADC Therapeutics | 8-K: ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
ADC Therapeutics | 10-K: FY2023 Annual Report
ADC Therapeutics | 8-K: ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 20-F: FY2022 Annual Report
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)